Nanotechnology-based Drug Delivery Market - By Technology (Nanocrystals, Nanoparticles, Liposomes, Micelles), Application (Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective), Global Forecast, 2023

Description

List of Tables

Global nanotechnology-based drug delivery market size is poised to record over 12.5% CAGR from 2023-2032. The rising number of research activities for exploring nanoparticle-based oral drug delivery systems to offer improved drug solubility and bioavailability is revolutionizing the delivery of poorly water-soluble drugs. In recent years, there has been significant focus on the development of effective, safe, and commercially viable drug delivery platforms. The increasing advances in versatile nanocarrier platforms within the biotechnology and nanomedicine space will also contribute to the market growth.

The overall nanotechnology-based drug delivery industry is segmented based on technology, application, and region.

In terms of technology, the market size from the nanocrystals segment may record appreciable CAGR from 2023-2032. The growth can be attributed to the rising potential of nanocrystals in improving the solubility and bioavailability of wide range of drugs, especially in poorly water-soluble compounds. Nanocrystals also significantly augment the surface area needed for dissolution to render enhanced drug solubility whilst providing stable drug formulations via minimal aggregation and degradation.

With respect to application, the nanotechnology-based drug delivery market from the neurology segment will expand up to 2032. The unique properties offered by nanomaterials and nanoparticles help in the precise delivery of drugs across blood-brain barrier (BBB) as well as specific regions within the brain. Lately, nanoparticles are also engineered to facilitate neuroprotective agents and clot-dissolving drugs to limit brain damage during and after strokes. To that end, the rising burden of neurological disorders and conditions worldwide will add to the segment growth.

Regionally, APAC nanotechnology-based drug delivery industry size is projected to observe notable growth rate through 2032. This is due to the rising investments, government funding, academic research, as well as collaborations with pharmaceutical companies in China, Japan, South Korea, and India. The growing burden of cancer is also driving the need for nanotechnology in delivering chemotherapy drugs directly to tumor sites, limiting systemic side effects and enhancing the treatment outcomes. As per the National Institutes for Health, the estimated number of cancer cases in India reached 14,61,427 in 2022.

Product Code: 6208

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data Sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Global nanotechnology-based drug delivery market 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Regional trends
- 2.1.3 Technology trends
- 2.1.4 Application trends

Chapter 3 Nanotechnology-based Drug Delivery Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing prevalence of chronic conditions
  - 3.2.1.2 Increasing preference for personalized medicines
  - 3.2.1.3 Increasing advancements in nanomaterials
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Stringent regulatory policies
  - 3.2.2.2 High cost of nanotechnology drug delivery technique
3.3 Growth potential analysis
- 3.3.1 By technology
- 3.3.2 By application
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.6 Recent advancement and future prospects
3.7 FDA-approved nanotechnology-based products and clinical trials
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Company positioning matrix
4.4 Competitive analysis of major market players
4.5 Strategy dashboard, 2022

Chapter 5 Nanotechnology-based Drug Delivery Market Size and Forecast, By Technology (USD Million)

5.1 Key trends, by technology
5.2 Nanocrystals
5.3 Nanoparticles
5.4 Liposomes
5.5 Micelles
5.6 Other technologies

Chapter 6 Nanotechnology-based Drug Delivery Market Size and Forecast, By Application (USD Million)

6.1 Key trends, by application
6.2 Neurology
6.3 Oncology
6.4 Cardiovascular/Physiology
6.5 Anti-inflammatory/Immunology
6.6 Anti-infective
6.7 Other applications

Chapter 7 Nanotechnology-based Drug Delivery Market Size and Forecast, By Region (USD Million)

7.1 Key trends, by region
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Rest of Europe
7.4 Asia Pacific
- 7.4.1 Japan
- 7.4.2 China
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East & Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 Rest of Middle East & Africa

Chapter 8 Company Profiles

8.1 AbbVie Inc.
8.2 BlueWillow Biologics
8.3 Camurus AB
8.4 Celgene, Inc.
8.5 Cristal Therapeutics
8.6 Johnson and Johnson
8.7 Merck and Co., Inc
8.8 Nanobiotix
8.9 NanoCarrier Co. Ltd.
8.10 NanOlogy LLC
8.11 Novartis International AG
8.12 Starpharma Holdings Limited